ADOCIA Announces Oral Presentations on AdoShell Islets at EASD and IPITA-IXA-CTRMS Congresses

25.09.2023 - Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and other metabolic diseases, ... Seite 1

Related Keywords

Hamburg ,Germany ,Courbebaisse ,Aquitaine ,France ,United States ,Paris ,France General ,San Diego ,California , ,International Pancreas ,European Association For The Study Of Diabetes ,Regenerative Medicine Society ,Islet Transplant Association ,International Xenotransplantation Association ,Regulatory News ,Euronext Paris ,Adoshell Islets ,Annual Meeting ,European Association ,Paris Hall ,Cell Transplant ,Adocia Chart ,Docia Kurs ,Docia Aktie ,